Cellectis

(OTC) CMVLF

Current Price$3.47

Market Cap$250.97M

Since IPO (2013)-25%

5 Year-77%

1 Year+178%

1 Month+13%

Cellectis Financials at a Glance

Market Cap

$250.97M

Revenue (TTM)

$68.09M

Net Income (TTM)

-$67.25M

EPS (TTM)

-$0.67

P/E Ratio

-5.18

Dividend

$0.00

Beta (Volatility)

0.10 (Low)

Dividend

$0.00

Beta (Volatility)

0.10 (Low)

Price

$3.47

Volume

Open

$3.47

Price

$3.47

Volume

Open

$3.47

Previous Close

$3.47

Daily Range

$3.47 - $3.47

52-Week Range

$1.25 - $5.04

Estimated Earnings Date

Aug 11, 2026

Dividend

$0.00

Beta (Volatility)

0.10 (Low)

Price

$3.47

Volume

Open

$3.47

Previous Close

$3.47

Daily Range

$3.47 - $3.47

52-Week Range

$1.25 - $5.04

Estimated Earnings Date

Aug 11, 2026

CMVLF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cellectis

Industry

Biotechnology

Sector

Health Care

Employees

229

CEO

André Choulika, PhD

Website

www.cellectis.com

Headquarters

Paris, 75013, FR

CMVLF Financials

Key Financial Metrics (TTM)

Gross Margin

79%

Operating Margin

-69%

Net Income Margin

-99%

Return on Equity

-76%

Return on Capital

-30%

Return on Assets

-23%

Earnings Yield

-19.31%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$250.97M

Shares Outstanding

72.33M

Volume

Avg. Volume

27.797

Financials (TTM)

Gross Profit

$55.04M

Operating Income

-$42.00M

EBITDA

-$21.12M

Operating Cash Flow

-$41.64M

Capital Expenditure

-$2.46M

Free Cash Flow

-$44.10M

Cash & ST Invst.

$208.67M

Total Debt

$119.91M

Cellectis Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$5.71M

-46.5%

Gross Profit

$1.23M

-85.8%

Gross Margin

21.50%

N/A

Market Cap

$250.97M

N/A

Market Cap/Employee

$1.16M

N/A

Employees

216

N/A

Net Income

-$17.54M

+3.2%

EBITDA

-$22.19M

-96.6%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$186.17M

-23.0%

Total Debt

$108.90M

+18.7%

Accounts Receivable

$12.78M

-49.9%

Inventory

$0.00

N/A

Long Term Debt

$93.70M

+18.8%

Short Term Debt

$15.20M

+17.8%

Return on Assets

-23.26%

N/A

Return on Invested Capital

-30.50%

N/A

Free Cash Flow

-$15.57M

+11.3%

Operating Cash Flow

-$15.31M

+10.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CLVLFClinuvel Pharmaceuticals Limited

CLVLFClinuvel Pharmaceuticals Limited$6.10+0.00%

NWBONorthwest Biotherapeutics, Inc.

NWBONorthwest Biotherapeutics, Inc.$0.20+6.92%

SLNCFSilence Therapeutics plc

SLNCFSilence Therapeutics plc$1.06+0.00%

CYDYCytoDyn Inc.

CYDYCytoDyn Inc.$0.29+0.69%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

Questions About CMVLF

What is the current price of Cellectis?

Cellectis is trading at $3.47 per share.

What is the 52-week range for Cellectis?

Over the past 52 weeks, Cellectis has traded between $1.25 and $5.04.

How much debt does Cellectis have?

As of the most recent reporting period, Cellectis reported total debt of $108.60M.

How much cash does Cellectis have on hand?

Cellectis reported $35.00M in cash and cash equivalents in its most recent financial results.

What is Cellectis’s dividend yield?

Cellectis does not currently have a dividend yield.

Cellectis

Cellectis Financials at a Glance

CMVLF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cellectis

CMVLF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cellectis Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CMVLF

What is the current price of Cellectis?

What is the 52-week range for Cellectis?

How much debt does Cellectis have?

How much cash does Cellectis have on hand?

What is Cellectis’s dividend yield?

Premium Investing Services